Minerva Neurosciences NERV
NASDAQ NERV
$2.30 -0.11 (-4.40%)
As of: Oct 23, 2026 · 3:25 PM EDT

Minerva Neurosciences (NERV) Other Investing Activities (2015)

Updated

Analysis

Minerva Neurosciences (NERV) Other Investing Activities (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,129.53 Bn 1,098.12 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 635.66 Bn 555.53 Bn 17.30 Bn 352.00 Mn
3 AbbVie 504.81 Bn 477.92 Bn 12.70 Bn -51.00 Mn
4 Merck 358.21 Bn 312.59 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 264.86 Bn 238.55 Bn 12.86 Bn 174.00 Mn
7 Amgen 237.58 Bn 192.98 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 194.88 Bn 169.08 Bn 6.22 Bn 20.00 Mn
9 Pfizer 171.14 Bn 117.79 Bn 10.94 Bn -1.00 Mn
10 Minerva Neurosciences 106.25 Mn -141.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -40,000.00
Mar 31, 2015 -4,986.00
API Access

Minerva Neurosciences Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=NERV&period=max&api_key=YOUR_API_KEY